arrow
M

Michael Linetsky

David Geffen School of Medicine at UCLA
H指数:13
被引数:644

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib

在评估非增强弥漫性神经胶质瘤中突变型IDH抑制时,首选体积测量: 来自ivosidenib的I期试验的证据

2021-11-0931
OA
C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma

Α b-晶体蛋白的C末端截短形式与间变性星形细胞瘤中的IDH1 R132H突变有关

2014-01-2912
PREAI